Phase 3 Respiratory Viral Infection Trials
2 Phase 3 trials for Respiratory Viral Infection. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.
What is a Phase 3 trial?
Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.
RECRUITINGPhase 3NCT07095257
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years...
The goal of this phase III study is to learn if ZX-7101A for oral suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years. The main...
Sponsor: Nanjing Zenshine PharmaceuticalsEnrolling: 1682 locations
RECRUITINGPhase 3NCT07357051
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric...
The goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.
Sponsor: Joincare Pharmaceutical Group Industry Co., LtdEnrolling: 1771 location